CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Tasso+™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06507566
NCT06507566N/ACompleted
CompareCT.gov

Phase 1 Study Evaluating Technologies for Point-of-Care Blood Collections in Support of Decentralized Outpatient Assessments in Pandemic and Clinical Trial Settings

Alachua Government Services, Inc.·interventional·Posted Jul 18, 2024·Updated Jan 23, 2026

In Brief

A clinical study evaluating Tasso+™ for Healthy. Completed, enrolled 200 participants across 1 site.

Detailed Summary

A study evaluating technologies for point-of-care use in clinical trials.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsICON plc, Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies

Timeline

N/ACompletedFinished
20252026
First PostedJul 18, 2024
Enrollment StartOct 29, 2024
Primary CompletionApr 4, 2025
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.0 years ago

Interventions

Tasso+™device

The Tasso+™ blood collection kit is a collection device (called the Tasso+™) and a capillary collection tube that allows for the storage of the blood in a liquid format in different matrices.